Mednet Logo
HomeQuestion

How would you approach a mediastinal-only presentation of squamous cell carcinoma of the lung s/p lymph node biopsy consistent with lung origin, with PET positive for only mediastinal disease?

5
3 Answers
Mednet Member
Mednet Member
Radiation Oncology · Wake Forest School of Medicine

First, I would confirm no prior cancer diagnosis, review in detail with a multidisciplinary tumor board, and try to rule out the non-lung primary site. If no primary can be found, and PET demonstrates limited disease only in the mediastinum/hilum, then I would just treat the disease that you can see...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Tennessee Oncology

If the patient is eligible for chemotherapy, I would strongly favor concurrent chemoradiation to 60Gy/30fx. The "one size fits all" involved-nodal-type approach for NSCLC volumes from our specialty frustrates me and I hope we eventually re-evaluate the potential benefit of elective nodal RT, but for...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Memorial Sloan Kettering Cancer Center

I agree with definitive concurrent chemoRT limited to the FDG-avid disease if no primary lesion is identifiable. T0N2 NSCLC is an entity that our group has described and seems to have relatively favorable outcomes with definitive RT. (Romesser et al., PMID 30642548). Subsequent NCBD analysis also su...

Register or Sign In to see full answer

How would you approach a mediastinal-only presentation of squamous cell carcinoma of the lung s/p lymph node biopsy consistent with lung origin, with PET positive for only mediastinal disease? | Mednet